Long-term incidence of relapse and post-kala-azar dermal leishmaniasis after three different visceral leishmaniasis treatment regimens in Bihar, India-Reference-Cited by-同舟云学术

Long-term incidence of relapse and post-kala-azar dermal leishmaniasis after three different visceral leishmaniasis treatment regimens in Bihar, India

Published:2020-07-20 Issue:7 Volume:14 Page:e0008429
ISSN:1935-2735
Container-title:PLOS Neglected Tropical Diseases
language:en
Short-container-title:PLoS Negl Trop Dis

Author:

Goyal Vishal,Das Vidya Nand Rabi,Singh Shambhu Nath,Singh Ravi Shankar,Pandey Krishna,Verma Neena,Hightower Allen,Rijal Suman,Das Pradeep,Alvar Jorge,Bern Caryn,Alves Fabiana^ORCID

Funder

Bill and Melinda Gates Foundation

Dutch Ministry of Foreign Affairs

UK Aid

Médecins Sans Frontières

Direktion für Entwicklung und Zusammenarbeit

Publisher

Public Library of Science (PLoS)

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health

Reference28 articles.

1. Eliminating visceral leishmaniasis in South Asia: the road ahead;S Rijal;BMJ,2019

2. Health-seeking behaviour, diagnostics and transmission dynamics in the control of visceral leishmaniasis in the Indian subcontinent;GF Medley;Nature,2015

3. The epidemiology of visceral leishmaniasis and asymptomatic leishmanial infection in a highly endemic Bangladeshi village;C Bern;Am J Trop Med Hyg,2007

4. The role of case proximity in transmission of visceral leishmaniasis in a highly endemic village in Bangladesh;LAC Chapman;PLoS Negl Trop Dis,2018

5. Ten years of kala-azar in west Bengal, Part I. Did post-kala-azar dermal leishmaniasis initiate the outbreak in 24-Parganas?;M Addy;Bull World Health Organ,1992

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Post kala-azar dermal leishmaniasis burden at the village level in selected high visceral leishmaniasis endemic upazilas in Bangladesh;International Journal of Infectious Diseases;2024-10

2. Shared challenges to the control of complex intracellular neglected pathogens;Frontiers in Public Health;2024-09-11

3. A phase II, non-comparative randomised trial of two treatments involving liposomal amphotericin B and miltefosine for post-kala-azar dermal leishmaniasis in India and Bangladesh;PLOS Neglected Tropical Diseases;2024-06-20

4. Visceral Leishmaniasis in a Twin Pregnancy: A Case Report and Review of the Literature;Journal of Clinical Medicine;2024-04-20

5. Modeling climate change impacts on vector-borne disease using machine learning models: Case study of Visceral leishmaniasis (Kala-azar) from Indian state of Bihar;Expert Systems with Applications;2024-03